Do Proton Pump Inhibitors Delay Gastric Emptying?

Man enjoying healthy salad bowl during outdoor business lunch

Written by Elias Darido, MD, FACS

Foregut & GERD Surgeon | Houston Heartburn and Reflux Center

15+ years in practice | Fellowship-trained at the University of North Carolina at Chapel Hill

Published: February 15, 2016 | Last Reviewed: September 19, 2026

Proton pump inhibitors (PPIs) are the most widely prescribed treatment for acid reflux. Many patients take them for years. Fewer know that PPIs also slow the emptying of solid food from the stomach.

That matters because slow emptying can itself promote reflux. If heartburn or bloating persists on a PPI, delayed gastric emptying may be part of the reason.

What the research shows

A 2010 systematic review by Sanaka, Yamamoto and Kuyama examined how PPIs affect gastric emptying.1 Among 14 studies of solid meals, 10 found a delay and 4 found no effect. Liquid emptying results were inconsistent.

Controlled human studies agree:

  • Parkman and colleagues gave omeprazole 20 mg daily for one week.2 Emptying after meals slowed. Ranitidine and famotidine had the same effect, so this appears to be a class effect of acid suppression. Antral contractility actually rose, which suggests weak contractions alone do not explain the delay.
  • Tougas and colleagues gave healthy volunteers omeprazole 20 mg twice daily for 14 days.3 Half-emptying time was significantly longer. Adding the prokinetic tegaserod prevented the delay.

Why acid suppression slows solid emptying

The mechanism is not fully understood. The leading explanation involves peptic hydrolysis. Acid activates pepsin, and pepsin helps break solid food into small particles. Particles must be small enough to pass through the pylorus. With less acid, fewer particles reach that size, so solids empty more slowly.1,5

Two other contributors have been proposed. Higher gastrin levels may play a minor role, though that link is conjectural.1,5 Reduced gastric fluid secretion may also raise the viscosity of stomach contents.4

Liquids behave differently. The review authors note that PPIs alter fluid volume and energy density. Liquid emptying then changes “in an unpredictable manner.”1

Why this matters in reflux disease

Delayed gastric emptying affects an estimated 10 to 30% of GERD patients. It can also promote reflux.

Transient lower esophageal sphincter relaxations (TLESRs) are a major cause of acid reflux. They increase after meals. Gastric fundus distention, pharyngeal stimulation and gastrointestinal hormones all contribute.

Slow emptying prolongs distention after a meal. Persistent delay may also stretch the fundus and increase its compliance. Either change could raise TLESR frequency and let more gastric juice reflux into the esophagus.

This is a hypothesis, not a proven conclusion. PPI therapy could work against reflux control in some patients even as it lowers acid. Whether long-term PPI use permanently changes fundus compliance remains unproven.

Bile reflux adds another concern. Some researchers speculate that PPIs alter esophageal bile exposure, with possible relevance to Barrett’s esophagus and adenocarcinoma. That link is unproven.

Keeping it in perspective

The delay is real but generally modest. PPIs still relieve GERD-associated dyspeptic symptoms such as bloating and early satiety, which argues against a large motility effect.4

The delay may also fade with long-term use. In rats, PPIs and potassium-competitive acid blockers (P-CABs) delayed emptying at two weeks. Emptying returned to baseline by four weeks.8 In healthy volunteers, the P-CAB tegoprazan appeared to affect solid emptying less than PPIs.5 The reason may be stimulation of phase III migrating motor complex contractions.5

Consensus statements do not endorse PPIs as treatment for gastroparesis itself.6,7 Their heavy use in gastroparesis is attributed mainly to coexisting GERD.

The bigger picture

PPIs treat acid. They do not target the mechanical and motility problems that cause reflux. Symptom control is often excellent. But TLESRs, fundus tone and esophageal clearance are not what these drugs address. That may explain why some patients keep having regurgitation, bloating or progressive symptoms despite good acid suppression. Better therapies should target those mechanisms rather than acid secretion alone.

Key Clinical Points

  • PPIs consistently delay emptying of solid meals. Their effect on liquid emptying is unpredictable.1
  • The leading explanation is reduced acid-dependent pepsin activity, which impairs the breakdown of solids.1,5
  • Delayed emptying affects an estimated 10 to 30% of GERD patients and may promote reflux through TLESRs.
  • The delay is generally modest. Whether it worsens reflux over time remains a hypothesis.
  • Dr. Darido personally performs the preoperative EGD, manometry, pH-impedance and upper GI contrast studies.

If reflux, bloating or early fullness continues despite a PPI, a full evaluation can clarify why. A gastric emptying study can be part of that evaluation when delayed emptying is suspected. Dr. Darido treats patients from Houston, The Woodlands, Katy, Sugar Land and Pearland. He also sees patients from across the United States. To schedule a consultation, contact Houston Heartburn and Reflux Center.

– Elias F. Darido, MD, FACS

Houston Heartburn and Reflux Center

Originally published: February 15, 2016 | Last reviewed: September 19, 2026

References

  1. Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review.Dig Dis Sci. 2010.
  2. Parkman HP, Urbain JL, Knight LC, et al. Effect of gastric acid suppressants on human gastric motility.Gut. 1998.
  3. Tougas G, Earnest DL, Chen Y, Vanderkoy C, Rojavin M. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.Aliment Pharmacol Ther. 2005.
  4. Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms.Clin Gastroenterol Hepatol. 2011.
  5. Lim HS, Yoon HJ, Jung HK, et al. Effects of tegoprazan, a potassium-competitive acid blocker, on gastric emptying and postprandial symptoms in healthy humans.Dig Dis Sci. 2025.
  6. Schol J, Wauters L, Dickman R, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.Neurogastroenterol Motil. 2021.
  7. Schol J, Huang IH, Carbone F, et al. Rome Foundation and International Neurogastroenterology and Motility Societies’ consensus on idiopathic gastroparesis.Lancet Gastroenterol Hepatol. 2025.
  8. Choi HS, Kim MS, Yu MH, et al. Long-term effects of potassium-competitive acid blockers and proton pump inhibitors on gastrin, gastric emptying rate, and small intestinal microbiota in rats.J Neurogastroenterol Motil. 2025.